奥洛兹美医疗

Halozyme Therapeutics 15min chart shows MACD Death Cross, Bollinger Bands narrowing.

Halozyme Therapeutics: 15min chart triggers RSI Overbought, KDJ Death Cross.

Halozyme Therapeutics' stock falls amid Bollinger Bands Narrowing and KDJ Death Cross signal.

Halozyme Therapeutics's 15min chart shows Bollinger Bands expanding downward, KDJ death cross.

Halozyme Therapeutics' 15-min chart shows MACD Death Cross, KDJ Death Cross.

Catalyst<ul> <li>Recent MACD Golden Cross and Hanging Man signals suggest potential for a bullish reversal in HALO.</li> <li>Fund flows show positive net inflow trends for medium, large, and extra-large orders, indicating institutional confidence.</li></ul>Risk<ul> <li>Multiple bearish signals, including MACD Death Cross and Long Lower Shadow, indicate ongoing downside pressure on HALO.</li> <li>Analyst ratings remain inconsistent, with one Neutral and one Strong Buy, reflecting uncertainty about HALO's outlook.</li> <li>Weak gross profit margin is a negative fundamental factor, signaling potential issues with profitability or cost management.</li></ul>

Key Factors

Halozyme Therapeutics forecasts $1.7B-$1.8B in revenue and $1.1B-$1.2B in adjusted EBITDA for 2026 driven by ENHANZE royalties and key products.

HALO News